Accessibility settings

This paper is in the following e-collection/theme issue:

Methods and Feasibility Studies (566) Cancer and Clinical Trials (52)

Published on in Vol 6, No 3 (2017): March

Use of the Total Cancer Care System to Enrich Screening for CD30-Positive Solid Tumors for Patient Enrollment Into a Brentuximab Vedotin Clinical Trial: A Pilot Study to Evaluate Feasibility

Use of the Total Cancer Care System to Enrich Screening for CD30-Positive Solid Tumors for Patient Enrollment Into a Brentuximab Vedotin Clinical Trial: A Pilot Study to Evaluate Feasibility

Use of the Total Cancer Care System to Enrich Screening for CD30-Positive Solid Tumors for Patient Enrollment Into a Brentuximab Vedotin Clinical Trial: A Pilot Study to Evaluate Feasibility

Authors of this article:

Bin Li1 Author Orcid Image ;   Steven A Eschrich2 Author Orcid Image ;   Anders Berglund2 Author Orcid Image ;   Melissa Mitchell3 Author Orcid Image ;   David Fenstermacher4 Author Orcid Image ;   Hadi Danaee5 Author Orcid Image ;   Hongyue Dai6 Author Orcid Image ;   Daniel Sullivan7 Author Orcid Image ;   William L Trepicchio5 Author Orcid Image ;   William S Dalton3 Author Orcid Image
Article Authors Cited by (6) Tweetations (2) Metrics

Altmetric

Altmetric discovers Social Media mentions. Click the ‘See more details’ link for a full report.

Dimensions

Dimensions discovers Citations. Click the ‘details’ link for a full report.

Metrics Since Publication

Download .csv
Daily | Monthly | Annually